We propose to engineer a molecule that will be ideally suited for arresting metastatic progression of breast cancer. This molecule will be designed to deliver a destructive radioisotope only to breast tumor cells. Both single metastatic cells and large tumors will be efficiently targeted. When used in multiple periodic administrations, the molecule should be able to prevent the recurrence of metastatic breast cancer.